SHEN, WANG,BARR, KENNETH,OSLOB, JOHAN D.,ZHONG, MIN
申请号：
CA2544678
公开号：
CA2544678C
申请日:
2004.11.05
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present invention provides compounds having formula (I): andpharmaceutically acceptable derivatives thereof, wherein R1-R4, n, p, A, B, D,E, L and AR1 are as described generally and in classes and subclasses herein,and additionally provides pharmaceutical compositions thereof, and methods forthe use thereof for the treatment of disorders mediated by the CD11/CD18family of cellular adhesion molecules (e.g., LFA-1).
